Anna P. Durbin

10.6k citations

126 papers · 6.4k indexed · 1 hit paper · h-index 48

Impact in

Infectious Diseases top 0.2%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
Public Health, Environmental and Occupational Health top 0.1%
- Mosquito-borne diseases and control
- Malaria Research and Control

Papers in

Infectious Diseases 96
- Viral Infections and Vectors 81
- Viral Infections and Outbreaks Research 20
Public Health, Environmental and Occupational Health 102
- Mosquito-borne diseases and control 99
- Malaria Research and Control 61

Co-authors: Stephen S. Whitehead Brian R. Murphy Joseph E. Blaney Peter L. Collins Beth D. Kirkpatrick Ruth A. Karron Kristen K. Pierce Sean A. Diehl
Journals: Vaccine (24 papers)Journal of Virology (13 papers)The Journal of Infectious Diseases (12 papers)American Journal of Tropical Medicine and Hygiene (8 papers)Virology (7 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Anna P. Durbin

124 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Prospects for a dengue virus vaccine 2007 · 477 citations

Peers

Countries citing papers authored by Anna P. Durbin

Since Specialization

Citations

This map shows the geographic impact of Anna P. Durbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna P. Durbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna P. Durbin more than expected).

Fields of papers citing papers by Anna P. Durbin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna P. Durbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna P. Durbin. The network helps show where Anna P. Durbin may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna P. Durbin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna P. Durbin Line = papers co-authored together Anna P. Durbin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Precision arbovirus serology with a pan-arbovirus peptidome Nature Communications ·William R. Morgenlander, Wan Ni Chia, Beatriz Parra, Daniel R. Monaco, Izabela Ragan, Carlos A. Pardo, Richard Bowen, Diana Zhong, Douglas E. Norris, Ingo Ruczinski, Anna P. Durbin, Lin‐Fa Wang, H. Benjamin Larman, Matthew L. Robinson	2024	6
2	TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies Journal of Clinical Investigation ·Kristen K. Pierce, Anna P. Durbin, MaryClaire Walsh, Marya P. Carmolli, Beulah P. Sabundayo, Dorothy M. Dickson, Sean A. Diehl, Stephen S. Whitehead, Beth D. Kirkpatrick	2023	14
3	Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model Pathogens ·Helton C. Santiago, Tertuliano Alves Pereira Neto, Marcela Helena Gonçalves-Pereira, Ana Carolina Bernardes Terzian, Anna P. Durbin	2022	9
4	A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans Nature Communications ·Usha K. Nivarthi, Jesica Swanstrom, Matthew J. Delacruz, B. L. Patel, Anna P. Durbin, Steve Whitehead, Beth D. Kirkpatrick, Kristen K. Pierce, Sean A. Diehl, Leah C. Katzelnick, Ralph S. Baric, Aravinda M. de Silva	2021	46
5	Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model Nature Communications ·John Hanley, Huy A. Tu, Julie A. Dragon, Dorothy M. Dickson, Roxana del Río, Scott Tighe, Korin Eckstrom, Nicholas Selig, Samuel V. Scarpino, Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, Beth D. Kirkpatrick, Donna M. Rizzo, Seth Frietze, Sean A. Diehl	2021	23
6	Implementation strategies for the first licensed dengue vaccine: A meeting report Vaccine ·Noah Fongwen, Isabelle Delrieu, Leong Hoe Ham, Duane J. Gubler, Anna P. Durbin, Eng Eong Ooi, Rosanna Ŵ. Peeling, Stefan Flasche, Kenneth Hartigan‐Go, Samuel Clifford, Carlos Torres Martinez, Xavier de Lamballerie, Till Bärnighausen, Annelies Wilder‐Smith	2021	13
7	Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model EBioMedicine ·Usha K. Nivarthi, Huy A. Tu, Matthew J. Delacruz, Jesica Swanstrom, B. L. Patel, Anna P. Durbin, Stephen S. Whitehead, Kristen K. Pierce, Beth D. Kirkpatrick, Ralph S. Baric, Ngan Nguyen, Daniel Emerling, Aravinda M. de Silva, Sean A. Diehl	2019	23
8	Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus PLoS neglected tropical diseases ·Leah C. Katzelnick, Ana Coello Escoto, Benjamin D. McElvany, Christian Chávez, Henrik Salje, Wensheng Luo, Isabel Rodríguez-Barraquer, Richard G. Jarman, Anna P. Durbin, Sean A. Diehl, Derek J. Smith, Stephen S. Whitehead, Derek A. T. Cummings	2018	45
9	In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination PLoS neglected tropical diseases ·Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, Dan Elwood, Benjamin D. McElvany, Ellen A. Fraser, Marya P. Carmolli, Cecilia Tibery, Noreen A. Hynes, Matthew Jo, Janece M. Lovchik, Catherine J. Larsson, Elena A. Doty, Dorothy M. Dickson, Catherine J. Luke, Kanta Subbarao, Sean A. Diehl, Beth D. Kirkpatrick	2017	80
10	Ethics, pregnancy, and ZIKV vaccine research & development Vaccine ·Ruth Faden, Carleigh Krubiner, Anne Drapkin Lyerly, Margaret Olivia Little, Allison August, Richard H. Beigi, Anna P. Durbin, Ruth A. Karron, Nancy Kass, F Franco Álvarez de Luna, Ricardo Palácios, Alexander Roberto Precioso, Carla Saénz, Jeanne S. Sheffield, Beatriz Thomé	2017	10
11	Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination Journal of Virology ·Usha K. Nivarthi, Nurgun Kose, Gopal Sapparapu, Douglas G. Widman, Emily N. Gallichotte, Jennifer M. Pfaff, Benjamin J. Doranz, Daniela Weiskopf, Alessandro Sette, Anna P. Durbin, Steve Whitehead, Ralph S. Baric, James E. Crowe, Aravinda M. de Silva	2016	39
12	Dengue Antibody and Zika: Friend or Foe? Trends in Immunology ·Anna P. Durbin	2016	33
13	WITHDRAWN: Dengue Human Infection Models to Advance Dengue Vaccine Development Vaccine ·Christian P. Larsen, Stephen S. Whitehead, Anna P. Durbin	2015	1
14	A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial The Journal of Infectious Diseases ·Anna P. Durbin, Beth D. Kirkpatrick, Kristen K. Pierce, Daniel Elwood, Catherine J. Larsson, Janet C. Lindow, Cecilia Tibery, Beulah P. Sabundayo, Donna Shaffer, Kawsar R. Talaat, Noreen A. Hynes, Kimberli Wanionek, Marya P. Carmolli, Catherine J. Luke, Brian R. Murphy, Kanta Subbarao, Stephen S. Whitehead	2013	129
15	Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria PLoS ONE ·Ruth D. Ellis, Yimin Wu, Laura B. Martin, Donna Shaffer, Kazutoyo Miura, Joan Aebig, Andrew C. Orcutt, Kelly M. Rausch, Daming Zhu, Anders Mogensen, Michael P. Fay, David L. Narum, Carole A. Long, Louis H. Miller, Anna P. Durbin	2012	45
16	Primary Vaccination with Low Dose Live Dengue 1 Virus Generates a Proinflammatory, Multifunctional T Cell Response in Humans PLoS neglected tropical diseases ·Janet C. Lindow, Nathan Borochoff-Porte, Anna P. Durbin, Stephen S. Whitehead, Kelly A. Fimlaid, Janice Y. Bunn, Beth D. Kirkpatrick	2012	34
17	A cost effectiveness analysis of the H1N1 vaccine strategy for Ontario, Canada Anna P. Durbin, A. N. Corallo, Theodoras G. Wibisono, Dionne M. Aleman, Brian Schwartz, Peter C. Coyte	2011	6
18	Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge Clinical Infectious Diseases ·David N. Taylor, R. McKenzie, Anna P. Durbin, Charles C. J. Carpenter, Chris Atzinger, R Haake, A. Louis Bourgeois	2006	50
19	Progress in the Development of Respiratory Syncytial Virus and Parainfluenza Virus Vaccines Clinical Infectious Diseases ·Anna P. Durbin, Ruth A. Karron	2003	60
20	Minimum Protein Requirements for Transcription and RNA Replication of a Minigenome of Human Parainfluenza Virus Type 3 and Evaluation of the Rule of Six Virology ·Anna P. Durbin, Jeffrey W. Siew, Brian R. Murphy, Peter L. Collins	1997	70

About Anna P. Durbin

Anna P. Durbin is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Modeling and Simulation, Virology and Epidemiology, having authored 126 papers that have together received 6.4k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (99 papers), Viral Infections and Vectors (81 papers), Malaria Research and Control (61 papers), Virology and Viral Diseases (23 papers), Viral Infections and Outbreaks Research (20 papers), Respiratory viral infections research (15 papers), COVID-19 epidemiological studies (7 papers) and HIV Research and Treatment (6 papers). The work is most often cited by research in Infectious Diseases (4.2k citations), Public Health, Environmental and Occupational Health (4.8k citations), Virology (397 citations), Modeling and Simulation (220 citations) and Insect Science (489 citations). Anna P. Durbin has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Stephen S. Whitehead, Brian R. Murphy, Joseph E. Blaney, Peter L. Collins, Beth D. Kirkpatrick, Ruth A. Karron, Kristen K. Pierce, Sean A. Diehl, Kimberli Wanionek and Theodore C. Pierson. Their work appears in journals such as Vaccine, Journal of Virology, The Journal of Infectious Diseases, American Journal of Tropical Medicine and Hygiene and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact